We detected higher percentages of CD8+IFN-γ+ and CD4+IFN-γ+ T cells (Fig. 1D, E), which paralleled a better control of tumor growth in mice bearing LLC-SULT2B1b tumors (Fig. 1F). The gene discussed is CD8A; the disease is neoplasm.